NCT04225390 2026-02-10
PROMIT
University of Erlangen-NĂŒrnberg Medical School
Phase 2 Completed
Clinical Trials
4 trialsNCT05223088 2025-03-18
Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IVăLarge Borrmann III Type and Bulky N Positive Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Completed
NCT04169841 2024-02-13
GUIDE2REPAIR
Centre Georges Francois Leclerc
Phase 2 Active not recruiting
NCT05479240 2023-06-18
Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting